| 
             
			
			 "It is our clear expectation that, according to the latest surveys 
			by the European Medicines Agency, the vaccines will receive 
			marketing authorisation in Europe early next year," Klaus Cichutek, 
			head of the Paul Ehrlich Institute, told a virtual press briefing on 
			Friday. 
			 
			(Reporting by Caroline Copley; editing by Thomas Seythal) 
			[© 2020 Thomson Reuters. All rights 
				reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content.  |